Abil Chempharma Private Limited - Due diligence report

A 360° intelligence report on Abil Chempharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2002-09-18 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
View plans
AC Abil Chempharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Abil Chempharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
87/100
Trust Score
Low Risk

Abil Chempharma Private Limited is assessed as Low Risk with a Trust Score of 87/100. Abil Chempharma Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 29 Jun 2026 from the latest processed filings. Abil Chempharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (67.00 cr) · 7 satisfied (79.07 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited3 48.0 cr
Others3 48.0 cr
Bank Of Baroda2 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (83 disclosure(s)).
  • 2 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SANKET JATIN GANDHI 01234567 Director 01/04/2018 6 yrs Approved
TEJAS CHAMPAKLAL SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.82 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 67.00 cr already registered.
  • Compliance record supports lending.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
30 Aug 2025
Charge created
Axis Bank Limited - 22.00 cr
22 Apr 2025
Charge satisfied
Axis Bank Limited
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Nov 2024
Charge satisfied
Others
10 Apr 2024
Director ceased
NIRAV VIKRAM MANIAR
29 Sep 2023
Director ceased
SANKET JATIN GANDHI
21 Aug 2023
Director appointed
SANKET JATIN GANDHI (Director)
25 Jul 2023
Charge satisfied
Others
25 Nov 2022
Charge created
Others - 12.50 cr
21 Sep 2022
Charge satisfied
State Bank Of India
30 Oct 2021
Charge created
State Bank Of India - 4.95 cr
03 Mar 2021
Charge created
Others - 5.62 cr
31 Mar 2019
Share transfer (FY 2019)
160000.00000000 shares to Namita Nirav Maniar
21 Feb 2019
Director ceased
AGAM LALIT SHAH
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Merillife U33110GJ1999PTC060787 Vapi, Gujarat, India
Chettinad Group U63012TN1999PTC118793 Chennai, Tamil Nadu, India
Bloom Electronics Private Limited U51100TZ1999PTC008841 Coimbatore, Tamil Nadu, India
Vaighai Agro Products U15132TN2010PLC074539 Madurai, Tamil Nadu, India
Provimi U24111KA1983PTC005213 Bangalore, Karnataka, India
Docon U60100MH2019PLC323444 Thane, Maharashtra, India
Icon Granito Private Limited U26933GJ2007PTC051625 Morbi, Gujarat, India
Bhartiya Global Ventures Private Limited U67120TN1999PTC128977 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Abil Chempharma Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Abil Chempharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Abil Chempharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Abil Chempharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Abil Chempharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Abil Chempharma Private Limited an active company?

Abil Chempharma Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Abil Chempharma Private Limited financially healthy?

Abil Chempharma Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Abil Chempharma Private Limited?

Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Abil Chempharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Abil Chempharma Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.

Is Abil Chempharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Abil Chempharma Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.